Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERLOTINIB vs ESCITALOPRAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERLOTINIB vs ESCITALOPRAM: Safety Overview

Metric ERLOTINIB ESCITALOPRAM
Total FAERS Reports 22,472 402
Deaths Reported 6,791 73
Death Rate 30.2% 18.2%
Hospitalizations 3,693 139
Average Patient Age 67.2 yrs 49.8 yrs
% Female Patients 59.8% N/A
FDA Approval Date Apr 16, 2020 N/A
Manufacturer Zydus Lifesciences Limited N/A
Route ORAL N/A
Marketing Status Discontinued N/A